Empiric Antibiotic Coverage for Undifferentiated Fever and Rigors
Without a clear source of infection identified, I would not recommend empiric antibiotics at this time—instead, pursue urgent diagnostic workup including blood cultures, urinalysis with culture, and chest imaging to identify the source before initiating antimicrobials.
Clinical Reasoning
Your patient presents with:
- 4 days of fever and rigors (suggesting bacteremia/systemic infection)
- Negative URI testing
- Resolved mild abdominal discomfort (making intra-abdominal source less likely)
- No identified source
Why Diagnostic Workup Takes Priority
The evidence strongly supports that adequate empiric therapy requires knowing the likely source and pathogens 1, 2. While early antibiotics are critical for sepsis (within 1 hour for septic shock) 1, your patient's clinical stability over 4 days suggests time for targeted diagnostics rather than blind empiric coverage.
Key pitfall to avoid: Starting antibiotics before obtaining blood cultures significantly reduces diagnostic yield and may obscure the true pathogen, leading to prolonged inappropriate therapy.
If You Must Start Antibiotics Immediately
If the patient appears clinically toxic, hemodynamically unstable, or immunocompromised, then empiric broad-spectrum coverage is warranted:
For Community-Acquired Infection (Most Likely Scenario)
Single-agent options:
- Ceftriaxone 1-2g IV every 12-24 hours 3 - provides excellent gram-negative and gram-positive coverage for bacteremia from unknown source
- Levofloxacin 750mg IV every 24 hours 3 - if fluoroquinolone resistance rates are <10-20% locally
Add metronidazole 500mg IV every 8-12 hours 3 only if:
- Abdominal symptoms recur
- Aspiration risk exists
- Oral/dental source suspected
Critical Considerations Before Prescribing
- Obtain blood cultures (at least 2 sets) BEFORE antibiotics 3
- Check urinalysis and urine culture - urinary source is common with fever/rigors
- Assess for healthcare exposures - recent hospitalization, dialysis, nursing home residence would shift toward healthcare-associated pathogens requiring broader coverage 4, 5
If Healthcare-Associated Risk Factors Present
For patients with recent hospitalization, antibiotic exposure, or immunosuppression, broader coverage is needed:
- Piperacillin-tazobactam 3.375g IV every 6 hours 3 OR
- Meropenem 1g IV every 8 hours 3 for critically ill patients
These cover resistant gram-negatives including Pseudomonas and provide anaerobic coverage 3, 4.
The De-escalation Imperative
Whichever regimen you choose, plan to narrow therapy within 48-72 hours based on culture results 1, 2, 5. Prolonged broad-spectrum therapy without a documented resistant organism drives antimicrobial resistance and increases toxicity risk 6.
What This Patient Really Needs
Given the resolved abdominal symptoms and negative URI testing, the differential includes:
- Occult bacteremia (endocarditis, line infection if any central access)
- Urinary tract infection/pyelonephritis
- Early intra-abdominal process (though less likely with symptom resolution)
- Non-infectious causes (drug fever, malignancy, autoimmune)
The rigors strongly suggest bacteremia, making blood cultures essential before antibiotics blur the picture.